| Date Filed | Type | Description |
| 08/25/2023 |
4
| LOSCALZO JOSEPH (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 15,000 options to buy
@ $2.21, valued at
$33.2k
|
|
| 07/19/2023 |
4
| LOSCALZO JOSEPH (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Exercised 1,777 restricted stock units
@ $0
Exercised 5,333 restricted stock units
@ $0 |
|
| 07/06/2023 |
4
| LOSCALZO JOSEPH (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 10,321 options to buy
@ $41.08, valued at
$424k
Granted 4,677 restricted stock units
@ $0 |
|
| 04/04/2023 |
4
| LOSCALZO JOSEPH (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 150,000 options to buy
@ $0.34, valued at
$51k
|
|
| 09/02/2022 |
4
| LOSCALZO JOSEPH (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 25,000 options to buy
@ $1.43, valued at
$35.8k
|
|
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2021 |
4
| LOSCALZO JOSEPH (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Exercised 5,333 restricted stock units
@ $0
Exercised 889 restricted stock units
@ $0
Exercised 666 restricted stock units
@ $0
Exercised 1,778 restricted stock units
@ $0 |
|
| 07/06/2021 |
4
| LOSCALZO JOSEPH (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 12,000 options to buy
@ $40.05, valued at
$480.6k
Granted 5,333 restricted stock units
@ $0 |
|
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2020 |
4
| LOSCALZO JOSEPH (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 10,000 options to buy
@ $1.97, valued at
$19.7k
|
|
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2020 |
4
| LOSCALZO JOSEPH (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 10,000 options to buy
@ $1.69, valued at
$16.9k
|
|
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2019 |
4
| LOSCALZO JOSEPH (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Exercised 666 restricted stock units
@ $0
Exercised 667 restricted stock units
@ $0
Exercised 889 restricted stock units
@ $0
Exercised 667 restricted stock units
@ $0
Granted 7,110 restricted stock units
@ $0
Granted 16,000 options to buy
@ $64.8, valued at
$1M
|
|
| 06/12/2019 |
4
| LOSCALZO JOSEPH (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 10,000 options to buy
@ $1.39, valued at
$13.9k
|
|
| 01/03/2019 |
4
| LOSCALZO JOSEPH (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 7,500 options to buy
@ $2, valued at
$15k
|
|
| 07/03/2018 |
4
| LOSCALZO JOSEPH (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Exercised 2,000 restricted stock units
@ $0
Exercised 667 restricted stock units
@ $0
Granted 3,555 restricted stock units
@ $0
Granted 16,000 options to buy
@ $42.88, valued at
$686.1k
|
|
| 04/20/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2018 |
4/A
| LOSCALZO JOSEPH (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Exercised 937 restricted stock units
@ $0 |
|
| 07/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/23/2017 |
4
| LOSCALZO JOSEPH (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC. |
| 01/23/2017 |
3
| LOSCALZO JOSEPH (Director) has filed a Form 3 on LEAP THERAPEUTICS, INC. |
| 07/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/28/2009 |
4
| LOSCALZO JOSEPH (Director) has filed a Form 4 on NITROMED INC |